Skip to main content
. 2017 Oct 12;38(11):1501–1511. doi: 10.1038/aps.2017.124

Figure 3.

Figure 3

Gefitinib inhibits the expression of specific M2-marker genes. Quantitative real-time PCR was performed to assess the mRNA levels of M2-marker genes. BMDMs were exposed to IL-13 (10 ng/mL) and treated with or without gefitinib (0.62 μmol/L) for 24 h. The results are presented as the mean±SEM of triplicate determination. *P<0.05; **P<0.01.